The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders
Abstract
Biomarkers are needed to assist in the diagnosis and medical management of various neurodegenerative disorders, including Alzheimer's disease (AD), Parkinson's disease (PD), and dementia with Lewy body (DLB). We have employed a multiplex quantitative proteomics method, iTRAQ (isobaric Tagging for Relative and Absolute protein Quantification), in conjunction with multidimensional chromatography, followed by tandem mass spectrometry (MS/MS), to simultaneously measure relative changes in the proteome of cerebrospinal fluid (CSF) obtained from patients with AD, PD, and DLB compared to healthy controls. The diagnosis of AD and DLB was confirmed by autopsy, whereas the diagnosis of PD was based on clinical criteria. The proteomic findings showed quantitative changes in AD, PD, and DLB as compared to controls; among more than 1,500 identified CSF proteins, 136, 72, and 101 of the proteins displayed quantitative changes unique to AD, PD, and DLB, respectively. Eight unique proteins were confirmed by Western blot analysis, and the sensitivity at 95% specificity was calculated for each marker alone and in combination. Several panels of unique makers were capable of distinguishing AD, PD and DLB patients from each other as well as from controls with high sensitivity at 95% specificity. Although these preliminary findings must be validated in a larger and different population of patients, they suggest that a roster of proteins may be generated and developed into specific biomarkers that could eventually assist in clinical diagnosis and monitoring disease progression of AD, PD and DLB.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378
Validity of the Trail Making Test as an Indicator of Organic Brain Damage
Reitan, R. M. (1958) · Perceptual and Motor Skills · doi:10.2466/pms.1958.8.3.271 · Cited by 7,928
Ross, P. L., Huang, Y. N., Marchese, J. N., Williamson, B., Parker, K., Hattan, S., Khainovski, N., Pillai, S., Dey, S., Daniels, S., et al. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m400129-mcp200 · Cited by 4,401
Self-citationDiagnostic Criteria for Parkinson Disease
Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822
Morris, J. C. (1997) · International Psychogeriatrics · doi:10.1017/s1041610297004870 · Cited by 1,641
The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service
Hughes, A. J., Daniel, S. E., Ben‐Shlomo, Y., & Lees, A. J. (2002) · Brain · doi:10.1093/brain/awf080 · Cited by 1,251
Mild cognitive impairment in the elderly: Predictors of dementia
Flicker, C., Ferris, S. H., & Reisberg, B. (1991) · Neurology · doi:10.1212/wnl.41.7.1006 · Cited by 838 · cited 1×
“Neuropsychological evaluation included: the MiniMental State Exam (MMSE) [13], Trail-Making Tests A and B [42], Clinical Dementia Rating Scale (CDR [37]), the Mattis and Coblentz Dementia Rating Scale score (DRS [32]) and the New York University (NYU) version of the Logical Memory II subscale (Immediate and Delayed Pa…”
MethodThe dynamic range of protein expression: A challenge for proteomic research
Corthals, G. L., Wasinger, V. C., Hochstrasser, D. F., & Sanchez, J.-C. (2000) · Electrophoresis · doi:10.1002/(sici)1522-2683(20000401)21:6<1104::aid-elps1104>3.0.co;2-c · Cited by 619
Accuracy of Clinical Diagnosis in Parkinsonism — A Prospective Study
Rajput, A. H., Rozdilsky, B., & Rajput, A. (1991) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100031814 · Cited by 596
Klunk, W. E., Bacskai, B. J., Mathis, C. A., Kajdasz, S. T., McLellan, M. E., Frosch, M. P., Debnath, M. L., Holt, D. P., Wang, Y., & Hyman, B. T. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.9.797 · Cited by 412
Self-citationA panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease
Carrette, O., Demalte, I., Scherl, A., Yalkinoglu, O., Corthals, G., Burkhard, P., Hochstrasser, D. F., & Sanchez, J. (2003) · PROTEOMICS · doi:10.1002/pmic.200300470 · Cited by 374
Characterization of four lipoprotein classes in human cerebrospinal fluid
Koch, S., Donarski, N., Goetze, K., Kreckel, M., Stuerenburg, H.-J., Buhmann, C., & Beisiegel, U. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31605-9 · Cited by 298
Litvan, I., MacIntyre, A., Goetz, C. G., Wenning, G. K., Jellinger, K., Verny, M., Bartko, J. J., Jankovic, J., McKee, A., Brandel, J. P., et al. (1998) · Archives of Neurology · doi:10.1001/archneur.55.7.969 · Cited by 298
Self-citationCombining Several Screening Tests: Optimality of the Risk Score
McIntosh, M. W., & Pepe, M. S. (2002) · Biometrics · doi:10.1111/j.0006-341x.2002.00657.x · Cited by 251
Self-citationProteomic studies of potential cerebrospinal fluid protein markers for Alzheimer’s disease.
Puchades, M., Hansson, S. F., Nilsson, C. L., Andreasen, N., Blennow, K., & Davidsson, P. (2003) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.08.005 · Cited by 245
The Evolution of Diagnosis in Early Parkinson Disease
Jankovic, J. (2000) · Archives of Neurology · doi:10.1001/archneur.57.3.369 · Cited by 229
Self-citationMCLEAN, B. N., LUXTON, R. W., & THOMPSON, E. J. (1990) · Brain · doi:10.1093/brain/113.5.1269 · Cited by 206
Tomimoto, H., Akiguchi, I., Suenaga, T., Nishimura, M., Wakita, H., Nakamura, S., & Kimura, J. (1996) · Stroke · doi:10.1161/01.str.27.11.2069 · Cited by 204
Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients
Davidsson, P., Westman-Brinkmalm, A., Nilsson, C. L., Lindbjer, M., Paulson, L., Andreasen, N., Sj??gren, M., & Blennow, K. (2002) · Neuroreport · doi:10.1097/00001756-200204160-00015 · Cited by 200
Kung Sutherland, M., Somerville, M. J., Yoong, L. K. K., Bergeron, C., Haussler, M. R., & Crapper McLachlan, D. R. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90032-7 · Cited by 196
Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma
McIntosh, M. W., Drescher, C., Karlan, B., Scholler, N., Urban, N., Hellstrom, K. E., & Hellstrom, I. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.07.039 · Cited by 193
Self-citationCSF biomarkers for mild cognitive impairment and early Alzheimer's disease
Andreasen, N., & Blennow, K. (2005) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2004.10.011 · Cited by 193
Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease
Zhang, J., Goodlett, D. R., Quinn, J. F., Peskind, E., Kaye, J. A., Zhou, Y., Pan, C., Yi, E., Eng, J., Wang, Q., et al. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7205 · Cited by 176
Self-citationQuantitative proteomic analysis of age-related changes in human cerebrospinal fluid
Zhang, J., Goodlett, D. R., Peskind, E. R., Quinn, J. F., Zhou, Y., Wang, Q., Pan, C., Yi, E., Eng, J., Aebersold, R. H., et al. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.03.012 · Cited by 169
Self-citationProteins released from degenerating neurons are surrogate markers for acute brain damage
Siman, R., McIntosh, T. K., Soltesz, K. M., Chen, Z., Neumar, R. W., & Roberts, V. L. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.03.016 · Cited by 164
Proteomic analysis of multiple sclerosis cerebrospinal fluid
Zhang, X. (2006) · Journal of Shandong University · Cited by 161
Clinical and Neuropathological Findings in Lewy Body Dementias
Galasko, D., Katzman, R., Salmon, D. P., & Hansen, L. (1996) · Brain and Cognition · doi:10.1006/brcg.1996.0040 · Cited by 153
CSF biomarkers for Alzheimer’s disease: use in early diagnosis and evaluation of drug treatment
Blennow, K. (2005) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.5.5.661 · Cited by 140
McKeith, I. G., Burn, D. J., Ballard, C. G., Collerton, D., Jaros, E., Morris, C. M., McLaren, A., Perry, E. K., Perry, R., Piggott, M. A., et al. (2003) · Seminars in Clinical Neuropsychiatry · doi:10.1053/scnp.2003.50006 · Cited by 135
Analysis of the human lumbar cerebrospinal fluid proteome
Yuan, X., Russell, T. M., Wood, G. W., & Desiderio, D. M. (2002) · Electrophoresis · doi:10.1002/1522-2683(200204)23:7/8<1185::aid-elps1185>3.0.co;2-g · Cited by 123
Comparative Proteomic Analysis of Intra- and Interindividual Variation in Human Cerebrospinal Fluid
Hu, Y., Malone, J. P., Fagan, A. M., Townsend, R. R., & Holtzman, D. M. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500207-mcp200 · Cited by 121
Shie, F., BREYER, R. M., & Montine, T. J. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62336-x · Cited by 118
Self-citationDetection of complement alternative pathway mRNA and proteins in the Alzheimer’s disease brain
Strohmeyer, R., Shen, Y., & Rogers, J. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00149-2 · Cited by 117
Imaging Amyloid-β Deposits In Vivo
Bacskai, B. J., Klunk, W. E., Mathis, C. A., & Hyman, B. T. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200209000-00001 · Cited by 115
Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease
Hochstrasser, H., Bauer, P., Walter, U., Behnke, S., Spiegel, J., Csoti, I., Zeiler, B., Bornemann, A., Pahnke, J., Becker, G., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000144276.29988.c3 · Cited by 111
The Use of Proteomics in Biomarker Discovery in Neurodegenerative Diseases
Davidsson, P., & Sjögren, M. J. C. (2005) · Disease Markers · doi:10.1155/2005/848676 · Cited by 93
Coagulation and inflammatory markers in Alzheimer's and vascular dementia
Gupta, A., Watkins, A., Thomas, P., Majer, R., Habubi, N., Morris, G., & Pansari, K. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2004.00143.x · Cited by 87
Protein Analysis in Cerebrospinal Fluid
Blennow, K., Fredman, P., Wallin, A., Gottfries, C., Skoog, I. G., Wikkelsø, C., & Svennerholm, L. T. (2008) · European Neurology · doi:10.1159/000116920 · Cited by 79
Ceruoplasmin Is Increased in Cerebrospinal Fluid in Alzheimerʼs Disease but Not Parkinsonʼs Disease
Loeffler, D. A., DeMaggio, A. J., Juneau, P. L., Brickman, C. M., Mashour, G. A., Finkelman, J., Pomara, N., & LeWitt, P. A. (1994) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199408030-00005 · Cited by 78
In Vivo Brain Imaging of Tangle Burden in Humans
Small, G. W., Agdeppa, E. D., Kepe, V., Satyamurthy, N., Huang, S., & Barrio, J. R. (2002) · Journal of Molecular Neuroscience · doi:10.1385/jmn:19:3:321 · Cited by 52
Post mortem sampling of the brain and other tissues in neurodegenerative disease
Love, S. (2004) · Histopathology · doi:10.1111/j.1365-2559.2004.01794.x · Cited by 41
Characterization of Proteome of Human Cerebrospinal Fluid
Xu, J., Chen, J., Peskind, E. R., Jin, J., Eng, J. K., Pan, C., Montine, T. J., Goodlett, D. R., & Zhang, J. (2006) · International review of neurobiology · doi:10.1016/s0074-7742(06)73002-1 · Cited by 29
Self-citation
Cited by
Identifying and validating biomarkers for Alzheimer's disease
Humpel, C. (2011) · Trends in Biotechnology · doi:10.1016/j.tibtech.2010.09.007 · Cited by 484
Mechanisms of Parkinson's Disease Linked to Pathological α-Synuclein: New Targets for Drug Discovery
Lee, V. M.-Y., & Trojanowski, J. Q. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.026 · Cited by 479
Vatansever, S., Schlessinger, A., Wacker, D., Kaniskan, H. Ü., Jin, J., Zhou, M., & Zhang, B. (2021) · Medicinal Research Reviews · doi:10.1002/med.21764 · Cited by 429
Potential markers of preeclampsia – a review
Grill, S., Rusterholz, C., Zanetti-Dällenbach, R., Tercanli, S., Holzgreve, W., Hahn, S., & Lapaire, O. (2009) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-7-70 · Cited by 293
CSF tau/Aβ 42 ratio for increased risk of mild cognitive impairment: A follow-up study
Li, G., Sokal, I., Quinn, J. F., Leverenz, J. B., Brodey, M., Schellenberg, G. D., Kaye, J. A., Raskind, M. A., Zhang, J., Peskind, E. R., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000267428.62582.aa · Cited by 279
Self-citation
Metadata
- Authors
- Abdi, F., Quinn, J. F., Jankovic, J., McIntosh, M., Leverenz, J. B., Peskind, E., Nixon, R., Nutt, J., Chung, K., Zabetian, C., Samii, A., Lin, M., Hattan, S., Pan, C., Wang, Y., Jin, J., Zhu, D., Li, G. J., Liu, Y., Waichunas, D., Montine, T. J., & Zhang, J.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2006-07-24
- Volume
- 9
- Issue
- 3
- Pages
- 293-348
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W111028273
- Cited by
- 384
- References
- 43
- FWCI
- 12.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.